Docking studies on novel analogs of quinolones

Excerpt:


J Pharm Pharmacogn Res 6(5): 386-391, 2018. Original Article | Artículo Original Docking studies on novel analogs of quinolones against DNA gyrase of Escherichia coli [Estudios de acoplamiento molecular de nuevos análogos de quinolonas a la ADN girasa de Escherichia coli] Cristian Davila1, Lorena Llach2, Guillermo Salgado-Moran3, Rodrigo Ramirez-Tagle4* 1Escuela de Química y Farmacia, Universidad Andrés Bello, Republica … Continue reading Docking studies on novel analogs of quinolones

J Pharm Pharmacogn Res 6(5): 386-391, 2018.

Original Article | Artículo Original

Docking studies on novel analogs of quinolones against DNA gyrase of Escherichia coli

[Estudios de acoplamiento molecular de nuevos análogos de quinolonas a la ADN girasa de Escherichia coli]

Cristian Davila1, Lorena Llach2, Guillermo Salgado-Moran3, Rodrigo Ramirez-Tagle4*

1Escuela de Química y Farmacia, Universidad Andrés Bello, Republica 237, Santiago, Chile.
2Facultad de Salud, Universidad Bernardo O´Higgins, General Gana 1780, Santiago, Chile. 
 3Facultad de Ciencias Exactas, Departamento de Química, Universidad Andrés Bello, Autopista Concepción – Talcahuano 7100, Concepción, Chile.
4Facultad de Ingeniería, Ciencia y Tecnología, Universidad Bernardo O´Higgins, General, Av. Viel 1497, Santiago, Chile.

*E-mail: rramirez@ubo.cl

Abstract

Context: Bacterial resistance to antibiotics is the inevitable consequence of the use of antimicrobial agents. Thus, quinolones are an important class of antibacterials; these agents generally consist of a 1-subtituted-1,4-dihydro-4-oxopyridine-3-carboxylic acid moiety combined with an aromatic or heteroaromatic ring fused at the 5- and 6-position.

Aims: To determine the binding of quinolones to DNA gyrase of Escherichia coli.

Methods: An analysis was performed using an in silico approach to determine, by docking calculations and energy descriptors, the conformer of 4‐oxo‐1,4‐dihydroquinoline skeleton that forms the most stable complex with DNA gyrase of E. coli.

Results: The complex shows that the pose of the quinolones coincides with the amino acid residues Asp87, Thr88, Arg91 and Met92, which is expected to be critical in the binding of quinolones to DNA gyrase of E. coli. A series of quinolones were computationally designed, and the interactions between the quinolones and the amino acid residues of the DNA gyrase were calculated.

Conclusions: Among the designed compounds, compounds 105 and 115 exhibit higher binding energy values and interact with amino acids Asp87, Thr88, Arg91 and Met92.

Keywords: Arguslab; DNA gyrase; docking; Escherichia coli; quinolones.

[Supplementary Data]

Resumen

Contexto: La resistencia bacteriana a los antibióticos es la consecuencia inevitable del uso de agentes antimicrobianos. Por lo tanto, las quinolonas son una clase importante de antibacterianos; estos agentes generalmente consisten en un resto ácido 1-sustituido-1,4-dihidro-4-oxopiridina-3-carboxílico combinado con un anillo aromático o heteroaromático fusionado en las posiciones 5 y 6.

Objetivos: Determinar la unión de quinolonas a ADN girasa de Escherichia coli.

Métodos: Se realizó un análisis utilizando un enfoque in silico para determinar, mediante cálculos de unión y descriptores de energía, el confórmero del esqueleto de 4-oxo-1,4-dihidroquinolina que forma el complejo más estable con la ADN girasa de E. coli.

Resultados: El complejo muestra que la postura de las quinolonas coincide con los residuos de aminoácidos Asp87, Thr88, Arg91 y Met92, que se espera que sean críticos en la unión de quinolonas a ADN girasa de E. coli. Se diseñó computacionalmente una serie de quinolonas, y se calcularon las interacciones entre las quinolonas y los residuos de aminoácidos de la ADN girasa.

Conclusiones: Entre los compuestos diseñados, los compuestos 105 y 115 exhiben valores de energía de unión más elevados e interactúan con los aminoácidos Asp87, Thr88, Arg91 y Met92.

Palabras Clave: acoplamiento molecular; ADN girasa; Arguslab; Escherichia coli; quinolonas.

[Supplementary Data]

Download the PDF file .

Supplementary Data:

Download the PDF file .

Citation Format: Davila C, Llach L, Salgado-Moran G, Ramirez-Tagle R (2018) Docking studies on novel analogs of quinolones against DNA gyrase of Escherichia coli. J Pharm Pharmacogn Res 5(6): 386–391.

© 2018 Journal of Pharmacy & Pharmacognosy Research (JPPRes)

Alcohol gel and chlorhexidine in microbiota on hands
J. Pharm. Pharmacogn. Res., vol. 12, no. 1, pp. 184-192, Jan-Feb 2024. DOI: https://doi.org/10.56499/jppres23.1733_12.1.184 Original Article Alcohol in gel is as effective as chlorhexidine in the reduction of microbiota on hands in hospital nurses [El alcohol en gel es tan eficaz como la clorhexidina en la reducción de la microbiota de las manos en enfermeras … Continue reading Alcohol gel and chlorhexidine in microbiota on hands
Piperine-HPMC 2910 solid dispersion freeze drying
J. Pharm. Pharmacogn. Res., vol. 12, no. 1, pp. 175-183, Jan-Feb 2024. DOI: https://doi.org/10.56499/jppres23.1734_12.1.175 Original Article Enhancing the solubility and dissolution rate of piperine via preparation of piperine–hydroxypropyl methylcellulose 2910 solid dispersion system using freeze-drying method [Mejora de la solubilidad y la velocidad de disolución de la piperina mediante la preparación de un sistema de … Continue reading Piperine-HPMC 2910 solid dispersion freeze drying
Metabolomic of propolis in hypertension
J. Pharm. Pharmacogn. Res., vol. 12, no. 1, pp. 166-174, Jan-Feb 2024. DOI: https://doi.org/10.56499/jppres23.1705_12.1.166 Original Article Metabolomic study on the effect of Indonesian propolis in hypertensive rats [Estudio metabolómico del efecto del propóleo indonesio en ratas hipertensas] Ade Heri Mulyati1*, Henny Dwi Yanti1, Siti Warnasih1, Ahmad Sulaeman2, Mohamad Rafi3 1Department of Chemistry, Faculty of Mathematics … Continue reading Metabolomic of propolis in hypertension

© 2013-2020 by the authors; licensee JPPRes, Antofagasta, Chile. This journal is an open-access journal distributed under the terms and conditions of the Creative Commons Attribution license-Non Commercial 4.0 international. The content on this site is intended for health professionals. If you are not a health professional, please talk to your doctor about any doubts or concerns regarding your health

Made with ♥ by AVAGAX Studio